Send us Feedback

Pharmacopeia Drug Discovery (PCOP)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 30-SEP
2007		 31-DEC
2007		 31-MAR
2008		 30-JUN
2008		 30-SEP
2008
Cash & Equivalents 61.3M 30.2M 61.5M 31.0M 33.4M
Short Term Investments 20.1M 41.1M 0 13.5M 0
Accounts Receivable 1.01M 0 0 1.00M 0
Inventories 0 0 0 0 0
Pre-paid Expenses 1.64M 2.03M 1.57M 1.40M 822K
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 84.0M 73.3M 63.0M 46.8M 34.3M
Property, Plant & Equipment 12.9M 14.8M 15.0M 14.9M 14.1M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 2.25M 2.22M 2.06M 1.98M 1.72M
Total Long-Term Assets 15.2M 17.1M 17.0M 16.8M 15.8M
Accounts Payable 2.73M 2.87M 3.22M 2.51M 2.29M
Accrued Expenses 0 0 0 0 0
Short Term Debt 573K 1.07M 1.25M 1.23M 1.26M
Long Term Debt 1.62M 3.00M 3.00M 2.75M 2.42M
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 26.1M 26.8M 27.2M 27.4M 21.6M
Minority Interest 0 0 0 0 0
Total Liabilities 57.6M 67.3M 67.9M 66.1M 62.6M
Preferred Stock 0 0 0 0 0
Common Par 296K 296K 297K 297K 298K
Additional Paid-In Capital 121M 122M 123M 124M 124M
Retained Earnings -79.7M -99.0M -111M -126M -137M
Treasury Stock 0 0 0 0 0
Other Equity 0 0 0 0 0
Total Shareholder's Equity 41.6M 23.1M 12.2M -2.41M -12.6M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki